Herpes Zoster Novel Treatment Hope From Tasmanian Abalone Gets $1.2 Million Boost

The team aims to commercialize a novel treatment for Herpes simplex and Herpes zoster utilizing an extract.

In other News

March 14, 2023 News

Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report

Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published

Read more

March 7, 2023 News

Novotech Team at BIO Europe to Share Benefits of Expanded Global Operations

Singapore - Novotech, the leading Asia Pacific centred biotech CRO will be at BI

Read more

March 3, 2023 News

Experts Share Insights on Evolving Global Vaccine Landscape Including mRNA Trends

Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trial

Read more

February 10, 2023 News

Global Report: Robust Phase 1 Trial Growth Across Asia Pacific

Novotech, the leading Asia Pacific centred biotech CRO, has published a new global report on Phas

Read more

February 2, 2023 News

Asia Pacific Cell & Gene Research Growing 50% Faster than ROW

Novotech, the leading Asia Pacific focused biotech specialist CRO and recipient of the

Read more

January 10, 2023 News

Novotech Acquires US-based Drug Development Consulting Firm, CBR International - Expands Drug…

Novotech, the leading Asia Pacific centered biotech CRO today announced the acquisition of CBR In

Read more

Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report

Novotech Team at BIO Europe to Share Benefits of Expanded Global Operations

Experts Share Insights on Evolving Global Vaccine Landscape Including mRNA Trends

Acute Myeloid Leukemia (AML) - Global Clinical Trial Landscape-Focus on Asia Pacific

Rheumatoid arthritis– Global Clinical trial landscape- Focus on Asia Pacific

Alzheimer’s Disease

Keeping Pace With The Evolving Global Landscape In Vaccine Development

The Next Big Thing in Cancer Care

The biotech landscape: market trends, priorities, predictions, and pathways to FDA approval

Phase I study helps company secure second indication for lead product with Healthy volunteer study…

What are the benefits of a well-designed, robust preclinical development plan?

Multi-Specific Monoclonal Antibodies – Global Clinical Trial Landscape - Focus On Asia Pacific

Covid-19 Notice important updates

Find content relevant to:

Medical and Regulatory Consulting

Patient Recruitment and Site Selection

Early Phase Trials in Australia

Clinical Operations and Project Management

Biometrics and Data Management

Virtual Clinical Trials

Real world data

Laboratory Services

FLEX

Oncology CRO services

Pharmacometric Services

Drug Development Consulting

GMO Solutions

Liver Disease CRO services

Infectious diseases and Vaccines CRO services

Orphan and rare disease CRO services

Clinical and Regulatory Strategy

Our workplace culture reflects the passion of our people, and we will support you to develop and achieve at all stages of your career and life.

Novotech is the leading Asia-Pacific contract research organisation (CRO) providing clinical development services across all clinical trial phases and therapeutic areas and global product development and regulatory affairs consulting through our in-house biodesk team.

There are many reasons people love working at Novotech, but when you join it will be our open, inclusive, and flexible work culture that you notice first.

We are committed to providing ongoing professional development training, a competitive bonus structure, a supportive work environment, variety in their role, and the opportunity for career development and advancement across all areas of the organisation to our employees.

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

Search Novotech

In other News

Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report

Novotech Team at BIO Europe to Share Benefits of Expanded Global Operations

Experts Share Insights on Evolving Global Vaccine Landscape Including mRNA Trends

Global Report: Robust Phase 1 Trial Growth Across Asia Pacific

Asia Pacific Cell & Gene Research Growing 50% Faster than ROW

Novotech Acquires US-based Drug Development Consulting Firm, CBR International - Expands Drug…

Other relevant content